Items tagged with Access
New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment (post)
The costs of making drugs to treat viral hepatitis, HIV and TB are now so low that each disease could be treated for less than $90, Dr Andrew Hill of St Stephen’s AIDS Trust told the opening plenary of the International Congress on Drug Therapy in HIV Infection in Glasgow on Sunday (October 23).
India: New drugs, new hope (post)
Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for TB patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.
MSF offers access to new TB drug in SA (post)
After feeling ill for months, 16-year-old Sinethemba Kuse received the news that she had multidrug-resistant tuberculosis (MDR-TB) from her local clinic in Khayelitsha outside of Cape Town in December last year.
DG of Health Services calls activists ‘unstable’ at conference on TB (post)
Liverpool, 28 October 2016: In a further evidence proving that there is no room for critical voices in India disagreeing with government policies, the Director General of Health Services (DGHS) Dr Jagdish Prasad attending the 47th Union World conference on Lung health at Liverpool attacked the global health activists calling them “unstable”, “mentally unwell” when they came protesting, calling on Indian government to act and implement the policies and programs required to end TB in India.
The U.S. is standing in the way of cheaper drugs for the poor (post)
Every few months, a drug company gets caught cranking up prices. Most recently, Mylan, the maker of EpiPen, took its turn in the hot seat for raising the price of a lifesaving allergy treatment by 500 percent. Congress was rightly enraged and opened yet another inquiry into pharmaceutical price gouging. Mylan offered discount coupons.
Tajikistan: Stories from MSF's paediatric TB projects (post)
Delamanid is one of the first new TB medicines in over 50 years, and recently the project team in Dushanbe, Tajikistan's capital, started treating a young TB patient with it. It follows several months of preparations and negotiations with the Ministry of Health and its counterparts.
First surveys return data on the cycles of illness and poverty (post)
LIVERPOOL, England – Of all the hardships confronting tuberculosis patients in Vietnam, the most expensive is the time it takes. That includes the time lost to doctor visits in pursuit of a diagnosis, the time lost to getting and taking treatment. Then, for patients debilitated by illness and by the drugs hoped to deliver a cure, as well as for the family members who care for them, it includes the time lost that used to be spent working, particularly among families that had depended on every dollar coming in. Those costs alone account for about 68 percent of the costs of being a tuberculosis patient in Vietnam, and the reason that at least 59 percent of people being treated for the disease have incurred financial losses categorized as catastrophic by the World Health Organization.
The Lancet Commission report on essential medicines (post)
The Lancet Commission on Essential Medicines Policies, constituted in 2014, released its much-anticipated report, Essential medicines for universal health coverage.
Access to Medicine Index 2016 released (post)
The Access to Medicine Index 2016 was published today (November 14), analysing the top 20 research-based pharmaceutical companies. The index looks at how those companies make medicines, vaccines and diagnostics more accessible in low- and middle-income countries. The index found progress in companies’ efforts to improve access but little support for flexibilities enshrined in international trade rules.
India: Doctor’s tenacity nudges government to overhaul TB program (post)
In the last six years, Haryana-based Dr Raman Kakar compiled a list of 5,300 cases where patients had a relapse of tuberculosis (TB) even after completing the full medication dose. He learnt that in several cases patients had completed full course of medication on six occasions but the disease still resuscitated, forcing them to seek another dose.
Page 25 of 83 · Total posts: 0
←First 24 25 26 Last→